Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

ASCRS: 2017

Accelerated CXL for the Treatment of Infectious Keratitis

Show Description +

In addition to its use in halting the progression of keratoconus, CXL also has the potential to treat corneal infections, Farhad Hafezi, MD, PhD, says. Accelerated CXL for treatment of infectious keratitis is currently undergoing phase 2 and 3 clinical trials in 10 countries. Professor Hafezi says he is hopeful that someday photoactivated chromophore for keratitis CXL, or PACK-CXL, will not only be an adjuvant to antibiotics but a first-line treatment for early ulcers.

Posted: 4/28/2017

Accelerated CXL for the Treatment of Infectious Keratitis

In addition to its use in halting the progression of keratoconus, CXL also has the potential to treat corneal infections, Farhad Hafezi, MD, PhD, says. Accelerated CXL for treatment of infectious keratitis is currently undergoing phase 2 and 3 clinical trials in 10 countries. Professor Hafezi says he is hopeful that someday photoactivated chromophore for keratitis CXL, or PACK-CXL, will not only be an adjuvant to antibiotics but a first-line treatment for early ulcers.

Posted: 4/28/2017


Please log in to leave a comment.

More From ASCRS: 2017 Coverage

A Tale of Two Trifocals

Ruth Lapid-Gortzak, MD, PhD

Pocket Incision Insertion of Raindrop Inlay Induces Less Dry Eye

Jodhbir Mehta, MD, BSC(HONS), MBBS, FRCOPHTH, FRCS(ED)